BTG3 and lobular neoplasia: We found anti-RNP to be significantly more common among patients with lupus nephritis; conversely, based on data from the RELESSER registry, anti-Sm is more common, while the Iranian working group found ANA positivity to be more common in their patients with LN [42,43].